Market Overview:
The global Ginkgo Biloba Extract Injection market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of stroke and other central nervous system diseases, growing awareness about the benefits of Ginkgo biloba extract injections, and rising demand for effective treatments for memory decline and other brain function decline diseases. However, factors such as the high cost of Ginkgo biloba extract injections and limited reimbursement policies are likely to restrain the growth of this market in some regions.
Product Definition:
Ginkgo biloba extract injection is a medication used to improve blood circulation. It is used to treat conditions such as Raynaud's syndrome, intermittent claudication, and cerebral vascular insufficiency.
5ml:
5ml is the standard injection size for Ginkgo biloba extract. It's a 60% concentration of liquid extract of leaves and seeds of the ginkgo tree, which is widely used in dietary supplements to improve memory and increase cerebral blood flow. The product also helps to reduce symptoms associated with dementia such as irritability, restlessness, anxiety and confusion among others.
The global market for 5ml injections was valued at USD 35 million in 2016.
10ml:
Ginkgo biloba extract is used in the treatment of dementia, Alzheimer's disease, and other related brain diseases. It helps in improving blood circulation to the brain and enhances oxygen supply to the tissue. The product also helps in reducing cerebral pressure which is responsible for symptoms such as irritability, anxiety, restlessness and insomnia among others.
Application Insights:
Stroke and other CNS disease segment dominated the global ginkgo biloba extract injection market in 2017 owing to the high incidence of cerebrovascular disorders. According to a study published in NCBI, it is estimated that more than 300,000 people suffer from stroke every year globally. Moreover, another study states that around half a million people die due to stroke each year. Therefore, an increase in the prevalence of cerebrovascular disorders is expected to contribute towards higher demand for treatment options such as gingko biloba extract injections over the forecast period.
Memory decline and other brain function decline diseases are anticipated to be one of the fastest-growing application segments during the forecast period owing to increasing geriatric population across countries such as China and Japan who are at a high risk of developing these conditions due their low birth rate.
Regional Analysis:
North America dominated the global ginkgo biloba extract injection market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to high product consumption coupled with rising geriatric population and awareness about natural products among people of this region.
Asia Pacific is anticipated to witness significant growth over the coming years owing to increasing geriatric population, prevalence of various chronic diseases such as Alzheimer's disease, Parkinson's disease, stroke and other central nervous system disorders memory decline.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace. This is expected to drive the demand for Ginkgo Biloba Extract Injection products as they are known to improve cognitive function and memory in elderly patients.
- Growing awareness about the benefits of Ginkgo Biloba Extract Injection: There is growing awareness among consumers about the benefits of Ginkgo Biloba Extract Injection products, which is likely to boost demand in the coming years.
- Rising incidence of neurodegenerative diseases: The incidence of neurodegenerative diseases such as Alzheimer’s and dementia is on the rise, which is expected to fuel demand for Ginkgo Biloba Extract Injection products over the forecast period.
- Technological advancements: With technological advancements, manufacturers are introducing new and innovative forms of Ginkgo Biloba Extract Injection products that are easier to administer and provide better results than traditional formulations. This is likely to spur market growth in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Ginkgo Biloba Extract Injection Market Research Report
By Type
5ml, 10ml
By Application
Stroke and Other Central Nervous System Disease, Memory Decline and Other Brain Function Decline Disease
By Companies
Schwabe, Ipsen, Kanion Pharma, Baiyu Group, Yuekang Pharma, Pude Pharma, Guizhou CCI, Chemfuture Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
160
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global Ginkgo Biloba Extract Injection Market Report Segments:
The global Ginkgo Biloba Extract Injection market is segmented on the basis of:
Types
5ml, 10ml
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Stroke and Other Central Nervous System Disease, Memory Decline and Other Brain Function Decline Disease
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Schwabe
- Ipsen
- Kanion Pharma
- Baiyu Group
- Yuekang Pharma
- Pude Pharma
- Guizhou CCI
- Chemfuture Pharma
Highlights of The Ginkgo Biloba Extract Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 5ml
- 10ml
- By Application:
- Stroke and Other Central Nervous System Disease
- Memory Decline and Other Brain Function Decline Disease
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ginkgo Biloba Extract Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ginkgo Biloba Extract Injection is a medication that is used to improve blood circulation.
Some of the major players in the ginkgo biloba extract injection market are Schwabe, Ipsen, Kanion Pharma, Baiyu Group, Yuekang Pharma, Pude Pharma, Guizhou CCI, Chemfuture Pharma.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ginkgo Biloba Extract Injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ginkgo Biloba Extract Injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ginkgo Biloba Extract Injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ginkgo Biloba Extract Injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ginkgo Biloba Extract Injection Market Size & Forecast, 2018-2028
4.5.1 Ginkgo Biloba Extract Injection Market Size and Y-o-Y Growth
4.5.2 Ginkgo Biloba Extract Injection Market Absolute $ Opportunity
Chapter 5 Global Ginkgo Biloba Extract Injection Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Ginkgo Biloba Extract Injection Market Size Forecast by Type
5.2.1 5ml
5.2.2 10ml
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Ginkgo Biloba Extract Injection Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Ginkgo Biloba Extract Injection Market Size Forecast by Applications
6.2.1 Stroke and Other Central Nervous System Disease
6.2.2 Memory Decline and Other Brain Function Decline Disease
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ginkgo Biloba Extract Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ginkgo Biloba Extract Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Ginkgo Biloba Extract Injection Analysis and Forecast
9.1 Introduction
9.2 North America Ginkgo Biloba Extract Injection Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Ginkgo Biloba Extract Injection Market Size Forecast by Type
9.6.1 5ml
9.6.2 10ml
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Ginkgo Biloba Extract Injection Market Size Forecast by Applications
9.10.1 Stroke and Other Central Nervous System Disease
9.10.2 Memory Decline and Other Brain Function Decline Disease
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Ginkgo Biloba Extract Injection Analysis and Forecast
10.1 Introduction
10.2 Europe Ginkgo Biloba Extract Injection Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Ginkgo Biloba Extract Injection Market Size Forecast by Type
10.6.1 5ml
10.6.2 10ml
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Ginkgo Biloba Extract Injection Market Size Forecast by Applications
10.10.1 Stroke and Other Central Nervous System Disease
10.10.2 Memory Decline and Other Brain Function Decline Disease
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Ginkgo Biloba Extract Injection Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Ginkgo Biloba Extract Injection Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Ginkgo Biloba Extract Injection Market Size Forecast by Type
11.6.1 5ml
11.6.2 10ml
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Ginkgo Biloba Extract Injection Market Size Forecast by Applications
11.10.1 Stroke and Other Central Nervous System Disease
11.10.2 Memory Decline and Other Brain Function Decline Disease
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Ginkgo Biloba Extract Injection Analysis and Forecast
12.1 Introduction
12.2 Latin America Ginkgo Biloba Extract Injection Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Ginkgo Biloba Extract Injection Market Size Forecast by Type
12.6.1 5ml
12.6.2 10ml
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Ginkgo Biloba Extract Injection Market Size Forecast by Applications
12.10.1 Stroke and Other Central Nervous System Disease
12.10.2 Memory Decline and Other Brain Function Decline Disease
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Ginkgo Biloba Extract Injection Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Ginkgo Biloba Extract Injection Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Ginkgo Biloba Extract Injection Market Size Forecast by Type
13.6.1 5ml
13.6.2 10ml
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Ginkgo Biloba Extract Injection Market Size Forecast by Applications
13.10.1 Stroke and Other Central Nervous System Disease
13.10.2 Memory Decline and Other Brain Function Decline Disease
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ginkgo Biloba Extract Injection Market: Competitive Dashboard
14.2 Global Ginkgo Biloba Extract Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Schwabe
14.3.2 Ipsen
14.3.3 Kanion Pharma
14.3.4 Baiyu Group
14.3.5 Yuekang Pharma
14.3.6 Pude Pharma
14.3.7 Guizhou CCI
14.3.8 Chemfuture Pharma
